Cancer Biomarkers Market to 2027 - Global Analysis and Forecasts By Biomarker Type (Protein Biomarkers, Genetic Biomarkers, Others); Profiling Technology (Omics Technologies, Imaging Technologies, Immunoassays, Cytogenetics, Bioinformatics); Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Leukemia, Bladder Cancer, Others); Application (Prognostics, Diagnostics, Research and Development, Others) and Geography
Publication Month: Oct 2019
Report Code: TIPBT00002663 No. of Pages: 241 Category: Biotechnology Status: Published
The global cancer biomarkers market is expected to reach US$ 31,206.00 Mn in 2027 from US$ 12,175.69 in 2018. The market is estimated to grow with a CAGR of 11.1% from 2019-2027.
Driving factors such as growing cancer prevalence across the globe, new product launches and FDA approvals, and technological advancements are expected to boost the market over the years. However, unfavorable regulatory and reimbursement scenario is likely to have a negative impact on the growth of the market in the coming years. In addition, the development opportunities in emerging countries are likely to have a positive effect on the growth of the market in the coming years.
Exhibit: Lucrative Regional Cancer Biomarkers Markets
Market Insights
New Product Launches & FDA Approvals
FDA approvals & product launches drive the market for cancer biomarkers. Market players are involved in the manufacturing wide range of cancer biomarkers that offer maximum advantages and early diagnosis. For instance, in May 2019, QIAGEN launched its first FDA-approved companion diagnostic for PIK3CA biomarkers to enhance precision medicine in breast cancer. PIK3CA Kit, the [PB1] first companion diagnostic assay are used in any cancer indication for the detection of activating mutations in the PIK3CA gene. Additionally, it is the first FDA approved test as guiding treatment decisions in breast cancer utilizing plasma specimens as a liquid biopsy. Moreover, In November 2017, Roche launched DISCOVERY [PB2] Teal HRP chromogen detection kit to improve tissue-based cancer research. This newest addition to the collection of modular-based detection kits is used to identify and profile biomarkers and cell populations in the tissue-based study.
Opportunity for development in emerging nations
The emerging markets like the Asia Pacific are creating better opportunities for significant market players to expand their business. This is a prime reason for market growth in the forecast period. Most of the major players focus on emerging countries such as India, China, and others owing to a large number of cancer patients and growing medical tourism in developing countries. Most of the emerging countries are preferred place for medical tourism. As per the Australian Institute of Health and Welfare, 140,000 new cases of cancer are diagnosed in 2018. Furthermore, according to the Malaysia Healthcare Travel Council, in 2017, Over 1,050,000+ healthcare travelers, visited Malaysia for healthcare purposes. The low cost of surgeries, advanced technologies with less waiting time for procedures in the region is likely to boost the demand for cancer biomarkers.
Product Insights
The global cancer biomarker market, based on biomarker type, has been segmented into genetic biomarkers, protein biomarkers, and other cancer biomarkers. The protein biomarkers segment held the largest share of the market in 2018. Moreover, the reagent segment is anticipated to register the highest CAGR in the market during the forecast period.
Exhibit: Cancer Biomarker Market, by Biomarker Type
Strategic Insights
Growth strategies through several organic and inorganic such as approvals, product launch, agreements, and partnerships have been witnessed in the market of cancer biomarkers. For instance, in June 2017, Illumina, Inc. announced an FDA-approved next-generation sequencing (NGS) kit, its Extended RAS Panel. This kit will be used on the Illumina MiSeqDx System and allows U.S. laboratories to help clinicians identify patients eligible for the treatment of metastatic colorectal cancer with Vectibix (panitumumab)
Global Cancer Biomarkers Market – By Biomarker Type
- Genetic Biomarkers
- Protein Biomarkers
- Other Cancer Biomarkers Diagnostics
Global Cancer Biomarkers Market – By Profiling Technology
- Omics Technologies
- Imaging Technologies
- Immunoassays
- Cytogenetics
- Bioinformatics Antibodies
Global Cancer Biomarkers Market – By Cancer Type
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Leukemia
- Bladder Cancer
- Other Cancer Types
Global Cancer Biomarkers Market – By Application
- Diagnostics
- Research and Development
- Prognostics
- Other Applications
BY GEOGRAPHY
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- UK
- Spain
- Italy
- Asia Pacific (APAC)
- China
- India
- Japan
- Australia
- South Korea
- Middle East & Africa (MEA)
- Saudi Arabia
- South Africa
- UAE
- South and Central America
- Brazil
- Argentina
Company Profiles
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- QIAGEN
- bioMérieux, Inc.
- Creative Diagnostics
- Hologic Inc.
- Quest Diagnostics
- Myriad Genetics, Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Cancer Biomarkers Market – By Biomarker Type
1.3.2 Global Cancer Biomarkers Market – By Profiling Technology
1.3.3 Global Cancer biomarkers Market – By Cancer Type
1.3.4 Global Cancer biomarkers Market – By Application
1.3.5 Global Cancer biomarkers Market – By Geography
2. Global Cancer biomarkers Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Cancer biomarkers Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Cancer Biomarkers Market - North America PEST Analysis
4.2.2 Cancer Biomarkers Market - Europe PEST Analysis
4.2.3 Cancer Biomarkers Market – Asia Pacific PEST Analysis
4.2.4 Cancer Biomarkers Market – Middle East & Africa PEST Analysis
4.2.5 Cancer Biomarkers Market – South and Central America PEST Analysis
5. Global Cancer Biomarkers Market – Key Industry Dynamics
5.1.1 Growing Cancer Prevalence Across The Globe
5.1.2 New Product Launches & FDA Approvals
5.1.3 Technological Advancements
5.2 Key Market Restraints
5.2.1 Unfavourable Regulatory and Reimbursement Scenario
5.3 Key Market Opportunities
5.3.1 Emerging Markets in Developing Countries
5.4 Future Trends
5.4.1 Inclination Towards Personalized Medicine
5.5 Impact Analysis
6. Cancer biomarkers Market – Global Analysis
6.1 Global Cancer biomarkers Market Revenue Forecasts And Analysis
6.2 Global Cancer biomarkers Market, By Geography - Forecasts And Analysis
6.3 Performance of Key Players
7. Cancer biomarkers Market Revenue And Forecasts To 2027 – Biomarker Type
7.1 Overview
7.2 Global Cancer Biomarkers Market Share by Biomarker Type 2018 & 2027 (%)
7.3 Genetic Biomarkers
7.3.1 Overview
7.3.2 Genetic Biomarkers Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Protein Biomarkers
7.4.1 Overview
7.4.2 Protein Biomarkers Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Other Cancer Biomarkers
7.5.1 Overview
7.5.2 Other Cancer Biomarkers Market Revenue and Forecast to 2027 (US$ Mn)
8. Cancer Biomarkers Market Analysis And Forecasts To 2027 – Profiling Technology
8.1 Overview
8.2 Global Cancer Biomarkers Market Share by Profiling Technology 2018 & 2027 (%)
8.3 Omics Technologies
8.3.1 Overview
8.3.2 Omics Technologies Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Imaging Technologies
8.4.1 Overview
8.4.2 Imaging Technologies Market Revenue and Forecast to 2027 (US$ Mn)
8.4.3 Ultrasound
8.4.3.1 Overview
8.4.3.2 Ultrasound Market Revenue and Forecast to 2027 (US$ Mn)
8.4.4 Computed Tomography (CT)
8.4.4.1 Overview
8.4.4.2 Computed Tomography (CT) Market Revenue and Forecast to 2027 (US$ Mn)
8.4.5 Magnetic Resonance Imaging (MRI)
8.4.5.1 Overview
8.4.5.2 Global Magnetic Resonance Imaging (MRI) Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.6 Positron Emission Tomography (PET) Market
8.4.6.1 Overview
8.4.6.2 Global Positron Emission Tomography (PET) Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Immunoassays
8.5.1.1 Overview
8.5.1.2 Immunoassays Market Revenue and Forecast to 2027 (US$ Mn)
8.6 Cytogenetics
8.6.1 Overview
8.6.2 Cytogenetics Market Revenue and Forecast to 2027 (US$ Mn)
8.7 Bioinformatics
8.7.1 Overview
8.7.2 Bioinformatics Market Revenue and Forecast to 2027 (US$ Mn)
9. Global Cancer biomarkers Market Revenue And Forecasts To 2027 – by Cancer Type
9.1 Overview
9.2 Global Cancer Biomarkers Market, By Cancer Type 2018 & 2027 (%)
9.3 Breast Cancer Market
9.3.1 Overview
9.3.2 Global Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Lung Cancer Market
9.4.1 Overview
9.4.2 Global Lung Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Prostate Cancer Market
9.5.1 Overview
9.5.2 Global Prostate Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Leukemia Market
9.6.1 Overview
9.6.2 Global Leukemia Market Revenue and Forecasts to 2027 (US$ Mn)
9.7 Bladder Cancer Market
9.7.1 Overview
9.7.2 Global Bladder Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
9.8 Other Cancer Market
9.8.1 Overview
9.8.2 Global Other Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
10. Global Cancer biomarkers Market Revenue And Forecasts To 2027 – by Application
10.1 Overview
10.2 Global Cancer Biomarkers Market, By Application 2018 & 2027 (%)
10.3 Diagnostics Market
10.3.1 Overview
10.3.2 Global Diagnostics Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
10.4 Research and Development Market
10.4.1 Overview
10.4.2 Global Research and Development Market Revenue and Forecasts to 2027 (US$ Mn)
10.5 Prognostics Market
10.5.1 Overview
10.5.2 Global Prognostics Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
10.6 Others Market
10.6.1 Overview
10.6.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
11. Cancer Biomarkers Market Revenue and Forecasts to 2027 – Geographical Analysis
11.1 North America Cancer Biomarkers Market Revenue And Forecasts To 2027
11.1.1 North America Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.2 North America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.1.3 North America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.1.3.1 North America Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.4 North America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.1.5 North America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.1.6 North America Cancer Biomarkers Market Revenue and Forecasts to 2027, By Country (%)
11.1.7 US Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.7.1 US Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.7.2 US Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.1.7.3 US Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.1.7.3.1 US Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.7.4 US Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.1.7.5 US Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.1.8 Canada Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.8.1 Canada Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.8.2 Canada Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.1.8.3 Canada Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.1.8.3.1 Canada Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.8.4 Canada Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.1.8.5 Canada Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.1.9 Mexico Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.9.1 Mexico Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.9.2 Mexico Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.1.9.3 Mexico Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.1.9.3.1 Mexico Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.9.4 Mexico Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.1.9.5 Mexico Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.2 Europe Cancer Biomarkers Market Revenue And Forecasts To 2027
11.2.1 Europe Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.2 Europe Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.2.3 Europe Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.2.3.1 Europe Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.4 Europe Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.2.5 Europe Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.2.6 Europe Cancer Biomarkers Market Revenue and Forecasts to 2027, By Country (%)
11.2.7 UK Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.7.1 UK Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.7.2 UK Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.2.7.3 UK Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.2.7.3.1 UK Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.7.4 UK Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.2.7.5 UK Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.2.8 Germany Cancer biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.8.1 Germany Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.8.2 Germany Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.2.8.3 Germany Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.2.8.3.1 Germany Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.8.4 Germany Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.2.8.5 Germany Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.2.9 France Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.9.1 France Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.9.2 France Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.2.9.3 France Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.2.9.3.1 France Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.9.4 France Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.2.9.5 France Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.2.10 Italy Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.10.1 Italy Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.10.2 Italy Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.2.10.3 Italy Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.2.10.3.1 Italy Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.10.4 Italy Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.2.10.5 Italy Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.2.11 Spain Cancer biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.11.1 Spain Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.11.2 Spain Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.2.11.3 Spain Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.2.11.3.1 Spain Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.11.4 Spain Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.2.11.5 Spain Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.3 Asia Pacific Cancer Biomarkers Market Revenue And Forecasts To 2027
11.4 Asia Pacific Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.1 Asia Pacific Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.4.2 Asia Pacific Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.4.2.1 Asia Pacific Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.3 Asia Pacific Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.4.4 Asia Pacific Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.4.5 Asia Pacific Cancer Biomarkers Market Revenue and Forecasts to 2027, By Country (%)
11.4.6 Japan Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.6.1 Japan Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.6.2 Japan Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.4.6.3 Japan Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.4.6.3.1 Japan Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.6.4 Japan Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.4.6.5 Japan Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.4.7 China Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.7.1 China Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.7.2 China Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.4.7.3 China Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.4.7.3.1 China Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.7.4 China Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.4.7.5 China Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.4.8 India Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.8.1 India Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.8.2 India Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.4.8.3 India Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.4.8.3.1 India Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.8.4 India Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.4.8.5 India Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.4.9 South Korea Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.9.1 South Korea Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.9.2 South Korea Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.4.9.3 South Korea Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.4.9.3.1 South Korea Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.9.4 South Korea Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.4.9.5 South Korea Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.4.10 Australia Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.10.1 Australia Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.10.2 Australia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.4.10.3 Australia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.4.10.3.1 Australia Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.10.4 Australia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.4.10.5 Australia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.5 Middle East & Africa Cancer biomarkers Market Revenue And Forecasts To 2027
11.5.1 Middle East & Africa Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.2 Middle East & Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.5.3 Middle East & Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.5.3.1 Middle East & Africa Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.4 Middle East & Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.5.5 Middle East & Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.5.6 Middle East & Africa Cancer biomarkers Market Revenue and Forecasts to 2027, By Country (%)
11.5.7 UAE Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.7.1 UAE Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.8 UAE Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.5.9 UAE Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.5.9.1 UAE Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.10 UAE Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.5.11 UAE Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.5.12 Saudi Arabia Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.12.1 Saudi Arabia Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.13 Saudi Arabia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.5.14 Saudi Arabia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.5.14.1 Saudi Arabia Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.15 Saudi Arabia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.5.16 Saudi Arabia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.5.17 South Africa Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.17.1 South Africa Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.18 South Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.5.19 South Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.5.19.1 South Africa Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.20 South Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.5.21 South Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.6 South And Central America Cancer Biomarkers Market Revenue And Forecasts To 2027
11.6.1 South and Central America Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.6.2 South and Central America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.6.3 South and Central America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.6.3.1 South and Central America Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.6.4 South and Central America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.6.5 South and Central America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.6.6 South and Central America Cancer Biomarkers Market Revenue and Forecasts to 2027, By Country (%)
11.6.7 Argentina Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.6.7.1 Argentina Cancer biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.6.8 Argentina Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.6.9 Argentina Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.6.9.1 Argentina Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.6.10 Argentina Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.6.11 Argentina Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.6.12 Brazil Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.6.12.1 Brazil Cancer biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.6.13 Brazil Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.6.14 Brazil Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.6.14.1 Brazil Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.6.15 Brazil Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.6.16 Brazil Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
12. Cancer Biomarkers Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies done by the companies in the Market, 2018 (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic developments
12.4.1 Overview
13. Cancer biomarkers Market–Key Company Profiles
13.1 Bio-Rad Laboratories, Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Financial Information
13.1.4 Product Portfolio
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Thermo Fisher Scientific, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Financial Information
13.2.4 Product Portfolio
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 F. Hoffmann-La Roche Ltd.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Financial Overview
13.3.4 Product Portfolio
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.5 Qiagen N.V.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Financial Overview
13.5.4 Product Portfolio
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.7 Illumina, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Financial Overview
13.7.4 Product Portfolio
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Myriad Genetics, Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Financial Overview
13.8.4 Product Portfolio
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Hologic Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Financial Overview
13.9.4 Product Portfolio
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Quest Diagnostics Incorporated
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Financial Overview
13.10.4 Product Portfolio
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 BioMérieux SA
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Financial Information
13.11.4 Product Portfolio
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Creative Diagnostics
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Financial Overview
13.12.4 Product Portfolio
13.12.5 SWOT ANALYSIS
13.12.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
Table 2. North America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
Table 3. North America Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 4. North America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
Table 5. North America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 6. US Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
Table 7. US Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
Table 8. US Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 9. US Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
Table 10. US Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 11. Canada Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
Table 12. Canada Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
Table 13. Canada Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 14. Canada Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
Table 15. Canada Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 16. Mexico Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
Table 17. Mexico Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
Table 18. Mexico Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 19. Mexico Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
Table 20. Mexico Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 21. Europe Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
Table 22. Europe Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
Table 23. Europe Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 24. Europe Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
Table 25. Europe Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 26. UK Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
Table 27. UK Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
Table 28. UK Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 29. UK Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
Table 30. UK Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 31. Germany Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
Table 32. Germany Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
Table 33. Germany Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 34. Germany Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
Table 35. Germany Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 36. France Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
Table 37. France Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
Table 38. France Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 39. France Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
Table 40. France Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 41. Italy Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
Table 42. Italy Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
Table 43. Italy Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 44. Italy Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
Table 45. Italy Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 46. Spain Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
Table 47. Spain Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
Table 48. Spain Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 49. Spain Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
Table 50. Spain Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 51. Asia Pacific Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
Table 52. Asia Pacific Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
Table 53. Asia Pacific Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 54. Asia Pacific Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
Table 55. Asia Pacific Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 56. Japan Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
Table 57. Japan Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
Table 58. Japan Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 59. Japan Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
Table 60. Japan Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 61. China Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
Table 62. China Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
Table 63. China Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 64. China Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
Table 65. China Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 66. India Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
Table 67. India Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
Table 68. India Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 69. India Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
Table 70. India Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 71. South Korea Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
Table 72. South Korea Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
Table 73. South Korea Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 74. South Korea Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
Table 75. South Korea Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 76. Australia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
Table 77. Australia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
Table 78. Australia Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 79. Australia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
Table 80. Australia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 81. Middle East & Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
Table 82. Middle East & Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
Table 83. Middle East & Africa Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 84. Middle East & Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
Table 85. Middle East & Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 86. UAE Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
Table 87. UAE Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
Table 88. UAE Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 89. UAE Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
Table 90. UAE Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 91. Saudi Arabia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
Table 92. Saudi Arabia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
Table 93. Saudi Arabia Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 94. Saudi Arabia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
Table 95. Saudi Arabia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 96. South Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
Table 97. South Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
Table 98. South Africa Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 99. South Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
Table 100. South Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 101. South and Central America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
Table 102. South and Central America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
Table 103. South and Central America Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 104. South and Central America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
Table 105. South and Central America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 106. Argentina Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
Table 107. Argentina Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
Table 108. Argentina Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 109. Argentina Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
Table 110. Argentina Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 111. Brazil Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
Table 112. Brazil Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
Table 113. Brazil Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 114. Brazil Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
Table 115. Brazil Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 116. Organic Developments Done By Companies
Table 117. Inorganic developments done by Companies
Table 118. Glossary of Terms, Cancer biomarkers Market
LIST OF FIGURES
Figure 1. Cancer Biomarkers Market Segmentation
Figure 2. Cancer Biomarkers Market Segmentation, by Region
Figure 3. Global Cancer biomarkers Market Overview
Figure 4. Protein Biomarker Segment Held Largest Share Of The Biomarker Type Segment In Cancer biomarkers Market
Figure 5. Asia Pacific Region Is Expected To Show Remarkable Growth During The Forecast Period
Figure 6. Global Cancer biomarkers Market, By Geography (US$ Mn)
Figure 7. Global Cancer Biomarkers Market- Leading Country Markets (US$ Mn)
Figure 8. Global Cancer biomarkers Market, Industry Landscape
Figure 9. Cancer Biomarkers Market - North America PEST Analysis
Figure 10. Cancer Biomarkers Market - Europe Pest Analysis
Figure 11. Cancer Biomarkers Market – Asia Pacific Pest Analysis
Figure 12. Cancer Biomarkers Market – Middle East & Africa Pest Analysis
Figure 13. Cancer Biomarkers Market – South and Central America PEST Analysis
Figure 14. Most Prevalent Forms of Cancers Globally, 2018
Figure 15. Cancer Biomarkers Market Impact Analysis of Driver and Restraints
Figure 16. Global Cancer biomarkers Market – Revenue Forecasts and Analysis – 2018- 2027
Figure 17. Global Cancer biomarkers Market – by Geography Forecasts and Analysis – 2018- 2027
Figure 18. Prominent Players in the Cancer biomarkers Market
Figure 19. Global Cancer Biomarkers Market Share by Biomarker Type 2018 & 2027 (%)
Figure 20. Genetic Biomarkers Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 21. Protein Biomarkers Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 22. Other Cancer Biomarkers Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 23. Global Cancer Biomarkers Market Share by Profiling Technology 2018 & 2027 (%)
Figure 24. Omics Technologies Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 25. Imaging Technologies Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 26. Ultrasound Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 27. Computed Tomography (CT)Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 28. Global Magnetic Resonance Imaging (MRI) Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. Global Positron Emission Tomography (PET) Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. Immunoassays Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 31. Cytogenetics Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 32. Bioinformatics Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 33. Global Cancer Biomarkers Market, by Cancer Type 2018 & 2027 (%)
Figure 34. Global Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 35. Global Lung Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 36. Global Prostate Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 37. Global Leukemia Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 38. Global Bladder Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 39. Global Other Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 40. Global Cancer Biomarkers Market, by Application 2018 & 2027 (%)
Figure 41. Global Diagnostics Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 42. Global Research and Development Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 43. Global Prognostics Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 44. Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 45. North America Cancer Biomarkers Market Revenue Overview, by Country (2018) (US$ Mn)
Figure 46. North America Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 47. North America Cancer Biomarkers Market Revenue and Forecasts to 2027, By Country (%)
Figure 48. US Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 49. Canada Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 50. Mexico Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 51. Europe Cancer Biomarkers Market Overview, by Country (2018)
Figure 52. Europe Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 53. Europe Cancer Biomarkers Market Revenue and Forecasts to 2027, By Country (%)
Figure 54. UK Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 55. Germany Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 56. France Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 57. Italy Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 58. Spain Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 59. Asia Pacific Cancer Biomarkers Market Overview, by Country (2018)
Figure 60. Asia Pacific Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 61. Asia Pacific Cancer Biomarkers Market Revenue and Forecasts to 2027, By Country (%)
Figure 62. Japan Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 63. China Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 64. India Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 65. South Korea Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 66. Australia Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 67. Middle East & Africa Cancer biomarkers Market Revenue Overview, by Country, 2018 (US$ Mn)
Figure 68. Middle East & Africa Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 69. Middle East & Africa Cancer biomarkers Market Revenue and Forecasts to 2027, By Country (%)
Figure 70. UAE Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 71. Saudi Arabia Cancer biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 72. South Africa Cancer biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 73. South and Central America Cancer Biomarkers Market Revenue Overview, by Country, 2018 (US$ Mn)
Figure 74. South and Central America Cancer biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 75. South and Central America Cancer Biomarkers Market Revenue and Forecasts to 2027, By Country (%)
Figure 76. Argentina Cancer biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 77. Brazil Cancer biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 78. Growth Strategies done by the companies in the Market, 2018 (%)
The List of Companies
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche Ltd.
- QIAGEN N.V.
- Illumina, Inc.
- Myriad Genetics, Inc.
- Hologic Inc.
- Quest Diagnostics Incorporated
- bioMérieux SA
- Creative Diagnostics
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cancer biomarkers market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global cancer biomarkers market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.